MMP2 and glioblastoma: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) inhibits messenger RNA (mRNA) expression of VEGF, together with matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) in different human glioblastoma cell lines.